In patients without platelet dysfunction, the presence of ADP reduces the platelet count to approximately zero, due to the aggregation of most platelets.
In the presence of platelet inhibition by P2Y 12 antagonists, not all the platelets aggregate reducing the difference between the initial platelet count and the postagonist count.